The SLC28A3 gene helps cells take up nucleosides, small molecules your body uses to build DNA and RNA, and it can also move some medicines into cells. If it does not work well, cells may handle these molecules less efficiently, and some people may process certain drugs differently. This gene can play a role in how your body responds to some cancer treatments, especially anthracyclines, including their effects on the heart. Most variants have little everyday effect, but a few may influence drug response.
What is a gene?
A gene is a piece of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which do much of the cell’s work. Others mainly guide when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can influence your response to food, stress, and medications. More detail on this topic is available in the LearnHub.
Overview
SLC28A3Gene function
What if the gene works
The SLC28A3 gene helps cells take in nucleosides, small building blocks used to make DNA and RNA. This supports routine cell growth, tissue repair, and the handling of some natural body signals.
Risk
What if the gene does not work
Changes in the SLC28A3 gene can reduce how well cells take up some DNA and RNA building blocks. Milder variants may partly lower transport, while more severe variants can greatly limit uptake and change their balance in cells.
Treatment
What does that mean for your treatment
No SLC28A3-specific treatment or management approach is currently established in clinical guidelines for people with a pathogenic or loss-of-function variant in the SLC28A3 gene. The SLC28A3 gene is being studied as a pharmacogenetic biomarker, especially for how some cancer drugs such as anthracyclines move into cells and may affect the chance of treatment-related heart problems.
Gene function
What if the gene works
Many cells need a steady supply of nucleosides, small molecules used to make DNA and RNA. The SLC28A3 gene helps move these molecules from outside the cell to the inside. Understanding what the SLC28A3 gene does in the body helps explain how cells reuse key building blocks every day.
The SLC28A3 gene makes a transporter protein that carries nucleosides across the cell membrane. This gives cells access to materials they use for routine growth and renewal.
Its transporter uses sodium to pull nucleosides into cells even when outside levels are lower. This helps cells gather and keep these building blocks efficiently.
Once nucleosides enter the cell, they can be reused to make DNA, RNA, and other essential molecules. This recycling supports everyday cell maintenance and helps conserve energy.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help explain normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change the function of a gene more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC28A3 gene can change the transporter protein’s shape, stability, or placement on the cell surface, which may reduce how well nucleosides (building blocks for DNA and RNA) move into cells. In work examining how SLC28A3 gene variants affect nucleoside transport, milder changes may partly lower activity, while more severe variants can leave very little working protein or stop transport almost completely. Some variants may also alter how the protein interacts with certain medicines at the cell membrane.
How variants are linked to conditions
The SLC28A3 gene does not yet have a broadly confirmed link to a specific health condition, though research on how SLC28A3 gene variants are linked to conditions is still developing. Anyone with a confirmed result involving the SLC28A3 gene should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are found throughout the general population. Most have no direct effect on health and are simply one aspect of natural human diversity. With many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, particularly when more than one gene and environmental factors play a role. In some instances, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC28A3, the clearest risk link is with heart damage from anthracycline chemotherapy, where certain gene changes can raise or lower risk. Risk also changes with the total drug dose, younger age at treatment, prior chest radiation, and existing heart problems.
Inheritance of SLC28A3 variants
There is not yet a broadly confirmed Mendelian inheritance pattern for health conditions linked to the SLC28A3 gene, although research continues to refine how inherited variants in this gene may affect traits such as medicine response. In practice, how variants of the SLC28A3 gene are inherited follows the usual pattern for genes on the numbered chromosomes. The SLC28A3 gene is located on chromosome 9, which is an autosome, so you inherit one copy from each parent.
What does my SLC28A3 result mean for my family?
There isn't yet a broadly confirmed family inheritance pattern tied to a specific health condition for SLC28A3, though this understanding can change as research develops. If you have a specific SLC28A3 result and questions about what it could mean for relatives, a doctor or genetic counselor can help explain it in the context of your family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the SLC28A3 gene works by reading DNA from a blood sample, saliva, or a cheek swab to look for variants. Results may show a common change, no notable variant, or a finding that needs expert interpretation to understand whether it is relevant to your care.
When should I consider getting a genetic test?
There is not yet a broadly established, SLC28A3-specific reason for routine genetic testing. Testing may be discussed with your doctor or a genetic counselor if you have a personal or family history of unusual reactions to certain chemotherapy medicines or other concerns that point to a broader genetics evaluation.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how much they reveal varies with the condition and the kind of variant found. How your body functions over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered with the rest of a person’s care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment may work well for one person, have less effect in another, or cause more side effects in someone else. Part of the reason is that inherited differences can change how the body absorbs, breaks down, transports, or responds to a drug. These differences are common and are one of several factors, along with age, other health conditions, and other medicines, that can shape treatment response.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. It looks at connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can help support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC28A3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday prescribing, so questions about medicines or side effects are best discussed with your doctor. SLC28A3 has been studied mainly in cancer care, where some research links it to the risk of heart side effects from anthracycline chemotherapy, but this has not become standard treatment guidance.
History
SLC28A3 entered the medical literature in the early 2000s, when researchers were mapping human genes involved in moving nucleoside related compounds into cells. It was first identified as part of a broader effort to understand why people can respond differently to certain medicines, especially cancer treatments. From these first observations, research expanded steadily, and SLC28A3 later became better known in pharmacogenetics through studies linking some variants to a lower chance of anthracycline related heart effects in some children and adults with cancer. This work helped move the gene from basic laboratory research into patient focused studies on treatment safety. Today, SLC28A3 is mainly recognized for its place in that growing history of personalized medicine.